Sanara MedTech (NASDAQ:SMTI – Get Free Report) had its price objective cut by equities researchers at Cantor Fitzgerald from $49.00 to $44.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 18.92% from […]
WINNIPEG, Manitoba, March 26, 2024 Kane Biotech Inc. today announces its fourth quarter and full year 2023 financial results. On December 20, 2023, Kane Biotech announced that it received a.
Kane Biotech Inc. (the "Company" or "Kane Biotech") today announces its fourth quarter and full year 2023 financial results. On December 20, 2023, Kane Biotech announced that it received a non-binding offer for its interest in STEM Animal Health..
WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at…